Market Share of Chronic Myelogenous Leukemia Treatment Industry
The chronic myelogenous leukemia treatment market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Bristol-Myers Squibb Co., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Mylan NV, Merck & Co. Inc, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, and Sanofi, among others.
Chronic Myelogenous Leukemia Treatment Market Leaders
Bristol-Myers Squibb Co
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Co. Ltd
Novartis AG
*Disclaimer: Major Players sorted in no particular order
